Weight Loss Drugs Improve Heart Health Regardless of Amount of Weight Lost

Health & LifestyleNews
174

Translate to Spanish or other 102 languages!

A new study finds that GLP-1 drugs’ heart health benefits may not be solely due to weight loss. Image for illustration purposes
A new study finds that GLP-1 drugs’ heart health benefits may not be solely due to weight loss. Image for illustration purposes

Mega Doctor News

- Advertisement -

As the popularity of glucagon-like peptide-1 (GLP-1) receptor agonists Trusted Source for weight loss — such as Wegovy and Zepbound — continues to grow, researchers continue to examine how these medications might impact other areas of a person’s health.

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/weight-loss-drug-helps-heart-regardless-of-amount-of-weight-lost?utm_term=feedcontent&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-10-28&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
AI Set to Transform Pediatric Neuro-Oncology
Next article
New TMA Guide Urges Screening for Colon Cancer

More Articles

Study: Supplement Plus Chemo Boosts Pancreatic Cancer Survival

L-glutamine, an amino acid that occurs naturally in the body and plays an important role in digestion, has been studied as a potential way to ease side effects in other cancers.

How Artificial Intelligence Is Improving Prostate Cancer Diagnostics

Mega Doctor News CLEVELAND CLINIC - September is Prostate Cancer Awareness Month.  Prostate cancer is...

New Strategies to Soothe Dry Eyes

Anyone who has ever endured burning, itchy eyes or extra tearing knows that these symptoms are tough to ignore.

FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder

The U.S. Food and Drug Administration today approved Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare blood disorder that causes the body to make too many red blood cells.
- Advertisement -